Guiru Li

机构：Dalian Medical University, Second Affiliated Hospital of Dalian Medical University, Shanghai University of Medicine and Health Sciences

发表论文 16 篇 · 总被引 178 次 · h-index 6

代表论文

• <p>Inhibition of tumor metastasis by targeted daunorubicin and dioscin codelivery liposomes modified with PFV for the treatment of non-small-cell lung cancer</p> (2019 · International Journal of Nanomedicine · 被引 60)
• Advances in Polymeric Micelles: Responsive and Targeting Approaches for Cancer Immunotherapy in the Tumor Microenvironment (2023 · Pharmaceutics · 被引 33)
• Sirtuin 5 Alleviates Liver Ischemia/Reperfusion Injury by Regulating Mitochondrial Succinylation and Oxidative Stress (2023 · Antioxidants and Redox Signaling · 被引 33)
• Proinflammatory cytokine IFN-γ, lncRNA BANCR and the occurrence of coronary artery disease (2019 · Life Sciences · 被引 18)
• Combination of betulinic acid and EGFR-TKIs exerts synergistic anti-tumor effects against wild-type EGFR NSCLC by inducing autophagy-related cell death via EGFR signaling pathway (2024 · Respiratory Research · 被引 17)
• Effects of different interventions on prognosis and quality of life in patients with atrial fibrillation (2022 · Annals of Noninvasive Electrocardiology · 被引 7)